Venus Remedies Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock of Venus Remedies Ltd hit its upper circuit price band of 5%, closing at Rs 1,555.8, the highest level ever recorded for the company. The price band capped the daily gain, effectively freezing trading at the ceiling price. This scenario indicates unfilled demand, as buyers were willing to purchase shares at or above this price, but sellers were absent, creating a supply-demand imbalance. The intraday range was relatively narrow, with a low of Rs 1,518.1 and a high locked at Rs 1,555.8, reflecting the circuit's mechanical constraint on price movement. What does the full demand picture look like for Venus Remedies once the circuit unlocks and normal trading resumes?

Delivery and Volume Analysis

Volume on the circuit day was 2.70572 lakh shares, translating to a turnover of approximately Rs 41.94 crore. While total traded volume is often lower on circuit days due to price lock, the delivery volume trend offers deeper insight into the quality of the move. Notably, delivery volume on 3 Jun 2026 fell by 29.07% compared to the 5-day average, registering 74,160 shares. This decline in delivery volume suggests that while the stock is experiencing strong buying interest, some of it may be speculative or intraday in nature rather than long-term accumulation. Is Venus Remedies' upper circuit move backed by genuine conviction or driven by short-term trading dynamics? The delivery data is the most revealing metric on a circuit day, and here it points to a mixed picture.

Moving Averages and Trend Context

Venus Remedies Ltd is trading above all major moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a strong bullish trend. The stock has been on a consistent upward trajectory, gaining nearly 51% over the past nine consecutive sessions. This sustained rally and the position above all key moving averages confirm that the upper circuit is not an isolated spike but part of a broader positive trend. The 5% gain today further cements this momentum, although the delivery volume dip tempers the enthusiasm somewhat.

Liquidity and Market Capitalisation Context

With a market capitalisation of approximately Rs 1,985 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is moderate, with the stock liquid enough to support a trade size of around Rs 0.28 crore based on 2% of the 5-day average traded value. While this liquidity is sufficient for retail and small institutional investors, it remains limited for larger trades, which can exacerbate price volatility and amplify circuit hits. The micro-cap status means that the upper circuit event carries a different weight compared to large-cap stocks, where liquidity is deeper and price moves more gradual. With limited liquidity and a Rs 1,985 crore market cap, should investors be cautious about chasing Venus Remedies at these levels?

Intraday Price Action

The stock opened with a gap up of 4.99%, immediately signalling strong buying interest. The intraday low was Rs 1,518.1, while the high was capped at Rs 1,555.8 due to the circuit limit. This narrow price range near the upper band is typical of circuit hits, where the price is mechanically prevented from moving higher despite persistent demand. The stock’s ability to maintain the upper circuit level throughout the session reflects sustained buying pressure, although the lack of sellers at these levels also contributes to the price lock.

Brief Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, an industry characterised by steady demand and innovation-driven growth. The company’s recent performance, including a 50.97% return over nine sessions, indicates strong market confidence. However, the dip in delivery volumes on the latest session suggests that some of the recent gains may be driven by short-term trading rather than sustained accumulation. This nuance is important for investors analysing the quality of the rally.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at Rs 1,555.8 capped a 5% gain for Venus Remedies Ltd, reflecting strong buying interest that outpaced available supply. However, the decline in delivery volume by 29.07% tempers the conviction narrative, suggesting that some of the buying may be speculative or intraday-driven rather than long-term accumulation. The stock’s position above all major moving averages confirms a bullish trend, but the micro-cap status and limited liquidity mean that price moves can be exaggerated and volatile. Investors should be mindful of the liquidity risk inherent in such stocks, where entering or exiting sizeable positions can be challenging. After a 5% single-day gain at upper circuit, is Venus Remedies still worth considering or has the move already happened?

Key Data at a Glance

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today